Atlas Trials

Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine

Clinical trial NCT01506570 · COMPLETED

Trial details

NCT number
NCT01506570
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dengue
Start date
2011-12-01
Primary completion
2013-09-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.